In melanoma, the balance of master regulator microphthalmia-associated transcription factor (MITF) and tyrosine kinase AXL has been shown to function as rheostat determining the transition between proliferative and invasive state—with highest MITF levels promoting neuronal differentiation [85]. This evidence concerns the gene MITF and melanoma.